Granules India’s wholly-owned foreign subsidiary-Granules Pharmaceuticals, Inc, had filed the Abbreviated New Drug Application (ANDA) for Colchicine tablets USP, 0.6 mg for which it has received US Food & Drug Administration (USFDA) approval.

Many of you might already be investing and some are still giving it a thought. So, here are a few tips of investing into mutual funds that would help you in getting a better experience.

Behavioural biases can hurt your financial well-being, as they tend to result in suboptimal decisions. Being aware of your behavioural biases help an individual take better decisions and thereby, be immune from losses that are avoidable.

Dilip Buildcon Limited has been declared as L-1 bidder for a new Hybrid Annuity Model (HAM) project, four-lane with paved shoulder configuration of Patrapali-Katghora (Km 53.300 to Km 92.600) Pkg-II of Bilaspur-Katghora section of NH-111, New NH-130 in the state of Chhattisgarh under Bharatmala on Hybrid Annuity Model by the National Highways Authority of lndia (NHAI).

The market opened in the green on February 6, 2020, overall volumes in futures & options currently stand at 2.74 crore contracts with a turnover of Rs. 19,60,373.95 crore.

The company’s consolidated cement production/purchase for January 2020 stood at 3,16,657 MT, up by 4.66 per cent, as compared to 3,02,558 MT produced in January, 2019.

The market opened in the green on February 6, 2020, overall volumes in futures & options currently stand at 2.74 crore contracts with a turnover of Rs. 19,60,373.95 crore.

Vaishali Pharma Limited has received a registration for three products including VMOX CV-1200, VMOX CV-600, and CYBUFIN-1,500 in Myanmar market. These products have a good demand in the local market of Myanmar.

The market opened in the green on February 6, 2020. The previous trading session witnessed the Sensex going up by 353.28 points to end at 41,142.66 and the Nifty was up by 109.50 points to close at 12,089.15. 

Pharma major-Lupin Limited announced, after the trading hours on Wednesday, that it has received approval from the United States Food and Drug Administration (USFDA) for its Leflunomide tablets USP, 10 mg and 20 mg. The drug is used for treating adults with active rheumatoid arthritis.